Aleix Prat

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Aleix Prat
Sep 1, 2024, 15:26 | Insight
Guillermo Villacampa: Meta-analysis evaluating immunotherapy in early breast cancer
Recently, an article by Guillermo Villacampa et al. was published in JAMA Oncology. "Neoadjuvant Immune…
Aug 23, 2024, 15:59 | Drugs
Aleix Prat: Our recent article on patritumab deruxtecan is on the list of Nature Communications' Editors’ Highlights
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared a post…
Jul 29, 2024, 11:19 | Insight
Rasha Aboelhassan: We can give TDM1 in stage I HER2 positive breast cancer
Rasha Aboelhassan shared a post on LinkedIn about a recent paper by Paolo Tarantino et al., commenting:…
Jul 25, 2024, 12:07 | Insight
Sonia Guedan: CAR affinity modulates CAR-T cells' sensitivity to PD-1/PD-L1 inhibition
Sonia Guedan, shared a post on X about a recent paper titled "CAR affinity modulates the…
Jul 25, 2024, 03:18 | Insight
6th and 7th ABC international consensus guidelines for the management of advanced breast cancer
ABC Global Alliance shared on LinkedIn: “Inequalities in access to care are a major hurdle…
Jul 22, 2024, 23:09 | Blog
Aleix Prat: TNBC-DX - new genomic profiling tool for the treatment of early-stage triple-negative breast cancer (TNBC)
Aleix Prat, Director of Cancer Institute and Blood Disorders at Clinical Hospital of Barcelona, shared…
Jul 22, 2024, 20:26 | Insight
How tumor biology impacts Patritumab deruxtecan's efficacy in early breast cancer
Sonia Guedan, Cancer Immunologist at Hospital Clinic Barcelona, posted on X: "Our colleague Aleix Prat's…
Jul 20, 2024, 11:01 | Insight
Paolo Tarantino: Thanks to ESMO for featuring our 5-year analysis of the ATEMPT randomized phase 3 trial
Paolo Tarantino shared a post on LinkedIn about a paper titled "Adjuvant Trastuzumab Emtansine Versus…
Jul 17, 2024, 12:35 | Insight
Aleix Prat: Our review article about HR+ breast cancer in young women
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared a post…
Jul 16, 2024, 23:13 | Blog
Benjamin Walbaum: Hormone receptor-positive early breast cancer in young women
Recently an article about: Hormone receptor-positive early breast cancer in young women: A comprehensive review…
Jul 15, 2024, 12:03 | Insight
Aleix Prat: Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared a post…
Jul 3, 2024, 22:59 | Blog
Aleix Prat: Our 2 articles published this week
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared on X:…
Jul 1, 2024, 15:23 | Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jun 14, 2024, 13:52 | Blog
Maria Vidal: Grateful to Ann Partridge and her team at DFCI for this amazing opportunity
Maria Vidal, Medical Oncologist at Hospital Clinic and IOB Institute of Oncology Barcelona, shared a…
May 31, 2024, 17:02 | Insight
Yakup Ergün: A guide where we can find answers to every question about aBC
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
May 19, 2024, 09:02 | Blog
Aleix Prat: HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants
Aleix Prat, CoFounder of Reveal Genomics, shared a post on X: "HER2‐low breast cancer in young…
May 19, 2024, 06:29 | Blog
Aleix Prat: EVOMET Conference: ‘Deconstructing the evolution of metastasis’  
Aleix Prat, CoFounder of Reveal Genomics, shared a post on X: "EVOMET Conference: ‘Deconstructing the evolution…
May 7, 2024, 03:53 | Blog
Aleix Prat: Dr. Tomás Pascual, will be co-presenting an educational talk alongside Sara Tolaney and Tatiana Prowell
Aleix Prat, Director of the Oncology Institute at Hospital Clínic Barcelona, shared a post on X:…
Apr 30, 2024, 05:53 | Blog
Paolo Tarantino: Grateful to e-join SIOM 2024!
Paolo Tarantino shared a post by Sarah Sammons, Medical Oncologist at Dana-Farber’s Breast Oncology Center…
Apr 28, 2024, 05:14 | Insight
Aleix Prat: Our new article about attitudes towards HER2DX in Spain
Aleix Prat, Director of the Cancer Institute at Hospital Clinic of Barcelona, shared on X/Twitter:…
Apr 22, 2024, 11:46 | Blog
Paolo Tarantino: The unmissable Harvard University breast cancer course is coming back on July 11-12
Paolo Tarantino, Research Fellow at Dana Farber Cancer Institute, shared on X: "The unmissable Harvard…
Apr 22, 2024, 11:40 | Blog
Sara Tolaney: Very excited to have Aleix Prat as the Schlager Lecturer at the Harvard Breast Course in July!
Sara Tolaney shared a post by Aleix Prat, Co-Founder of Reveal Genomics, on X/Twitter, adding:…
Jan 2, 2024, 18:10 | Insight
Aleix Prat: Excited to unveil our lab's TOP-11 2023 research articles in breast cancer
Aleix Prat, Director of Cancer Institute at Hospital Clinic of Barcelona, shared on LinkedIn: "Excited to…
All: 23 Posts: 1 - 100
Special Coverage